Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AAPG - ASCENTAGE PHARMA GROUP INTERNATIONAL

21.17
-0.120   -0.567%

Share volume: 167,273
Last Updated: Fri 21 Feb 2025 10:00:00 PM CET

PREVIOUS CLOSE
CHG
CHG%
$21.29
1.50
0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Historical prices Events Documents Notes Dividends
Performance
5 Days
14.37%
1 Month
22.72%
3 Months
22.72%
6 Months
22.72%
1 Year
22.72%
2 Year
22.72%
Key data
Stock price
$21.17
P/E Ratio 
N/A
DAY RANGE
$20.49 - $21.40
EPS 
N/A
52 WEEK RANGE
$17.00 - $21.40
52 WEEK CHANGE
$22.72
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$96,558
AVERAGE 30 VOLUME 
$154,061
Company detail
CEO: Dajun Yang
Region: US
Website: www.ascentage.com
Employees: 600
IPO year: 2025
Issue type:
Market: NASDAQ
Industry:
Sector:

We are a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies. Our headquarters and principal executive office is located in Suzhou, Jiangsu, China.

Recent news